Background: Human milk is unequivocally recognized as the optimal source of nutrition for vulnerable infants, particularly preterm and medically fragile newborns. Its unique composition provides essential nutrients, immunological protection, and bioactive components that cannot be replicated by formula, significantly reducing the risk of life-threatening complications such as necrotizing enterocolitis, sepsis, and long-term developmental impairments.For many neonates, especially those whose mothers are unable to provide sufficient milk, donor human milk becomes a critical, sometimes life-saving resource.Method: The growing demand for donor human milk has highlighted the limitations of traditional, non-commercial milk bank models, which often struggle with inconsistent supply, variable quality standards, and logistical challenges. In this context, the controlled commercialization of donor human milk processing and distribution emerges as a necessary step to ensure reliable access, standardized safety protocols, and consistent product quality on a larger scale.Commercial entities can provide the infrastructure, investment, and technological innovation required to implement rigorous screening, pasteurization, and quality assurance processes, thereby minimizing risks of contamination and ensuring the highest possible safety for recipients.Results: However, the introduction of commercial interests into the field of human milk banking raises significant ethical concerns. There is a risk that profit motives could undermine donor autonomy, exploit vulnerable populations, or compromise equitable access for the most at-risk infants.To address these challenges, it is imperative that commercialization is strictly governed by robust ethical frameworks. These must prioritize the health and well-being of infants, protect the rights and dignity of milk donors, and ensure that access to donor milk is determined by medical need rather than financial capacityKey ethical principles should include transparent donor recruitment and compensation practices, informed consent, non-coercive participation, and the prohibition of aggressive marketing or undue inducement.Furthermore, regulatory oversight must guarantee that commercial providers adhere to evidence-based clinical guidelines, maintain full traceability of milk donations, and uphold the highest standards of safety and quality control. Equitable access should be enshrined as a core value, with mechanisms to support the inclusion of marginalized and low-income families who might otherwise be excluded from the benefits of donor milk.Conclusion: While the commercialization of donor human milk is increasingly indispensable for meeting the nutritional needs of vulnerable infants at scale, it must be pursued within a transparent, ethically sound framework.Only by embedding clear ethical principles into every aspect of commercial human milk banking can we ensure that the irreplaceable benefits of human milk reach all infants in need—safely, equitably, and with the utmost respect for both donors and recipients.
